These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13705953)

  • 1. Some pharmacological actions of D-lysergic acid methyl carbinolamide.
    GLASSER A
    Nature; 1961 Jan; 189():313-4. PubMed ID: 13705953
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Butanolamide of 1-methyl-D-lysergic acid and histamine liberation].
    LECOMTE J; LAPIERE CM
    C R Seances Soc Biol Fil; 1960; 154():2386-9. PubMed ID: 13760117
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxytocic effect of some d-lysergic acid cycloalkylamides.
    VOTAVA Z; PODVALOVA I; SEMONSKY M
    Nature; 1957 Mar; 179(4557):474-5. PubMed ID: 13407748
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental studies with the butanolamide and propanolamide of 1-methyl-lysergic acid.
    GELFAND MD; WEST GB
    Int Arch Allergy Appl Immunol; 1961; 18():286-91. PubMed ID: 13704268
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.
    SICUTERI F
    Int Arch Allergy Appl Immunol; 1959; 15():300-7. PubMed ID: 14446408
    [No Abstract]   [Full Text] [Related]  

  • 9. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 10. [First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects].
    SICUTERI F
    Prog Med (Napoli); 1960 Jan; 16():20-2. PubMed ID: 14446409
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonism between an antiserotonin-the butanolamide of 1-methyl-lysergic acid--and the effects of a histamine-liberating substance 48/80 B. W. in man.
    SICUTERI F; MICHELACCI S; FRANCHI G
    Int Arch Allergy Appl Immunol; 1959; 15():291-9. PubMed ID: 14446403
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemical structure and lysergic acid derivative psychoses].
    SOLMS H
    Praxis; 1956 Aug; 45(32):746-9. PubMed ID: 13359249
    [No Abstract]   [Full Text] [Related]  

  • 13. A central nervous system effect of a nonhallucinatory lysergic acid derivative.
    SPIRTES MA; GUTH PS; POLLEY EH
    Experientia; 1958 Nov; 14(11):428. PubMed ID: 13609622
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of a new lysergic acid derivative in submerged culture by a strain of Claviceps paspali Stevens & Hall.
    ARCAMONE F; CHAIN EB; FERRETTI A; MINGHETTI A; PENNELLA P; TONOLO A; VERO L
    Proc R Soc Lond B Biol Sci; 1961 Oct; 155():26-54. PubMed ID: 14036841
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of tryptophan and methyltryptophans on submerged lysergic acid fermentation by Claviceps paspali Stevens and Hall.
    ARCAMONE F; CHAIN EB; FERRETTI A; MINGHETTI A; PENNELLA P; TONOLO A
    Biochim Biophys Acta; 1962 Feb; 57():174-6. PubMed ID: 13862059
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of substance P by lysergic acid diethvlamide in vivo.
    KRIVOY WA
    Br J Pharmacol Chemother; 1961 Jun; 16(3):253-6. PubMed ID: 13754427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-tumor action of lysergic acid derivatives and their serotonin-blocking effect as reflected by the I 131 distribution in rats.
    SCOTT KG; STONE RS
    Cancer Res; 1959 Aug; 19():783-7. PubMed ID: 14444248
    [No Abstract]   [Full Text] [Related]  

  • 18. Some vascular actions of 1-methyl-d-lysergic acid butanolamide with special reference to its reflex-blocking and antiserotonin actions.
    GEBBER GL; BECK L
    Med Bull (Ann Arbor); 1963; 29():182-94. PubMed ID: 13946952
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
    SICUTERI F
    Med Exp Int J Exp Med; 1960; 2():36-9. PubMed ID: 14446407
    [No Abstract]   [Full Text] [Related]  

  • 20. Actions of derivatives of lysergic acid on the heart of Venus mercenaria.
    WRIGHT AM; MOCRHEAD M; WELSH JH
    Br J Pharmacol Chemother; 1962 Apr; 18(2):440-50. PubMed ID: 14008412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.